@Davisite
2,600 vials of Zantrene were recently manufactured by Ardena in Europe. I can roughly work out the production cost per treatment based on quarterly spend.
Is the omission of this data intentional? One of the many attractive aspects of RC220's commercial opportunity is that it's relatively cheap to produce. Can you pls highlight this in the next strategy update?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
-0.040(3.23%) |
Mkt cap ! $208.4M | |||
| Open | High | Low | Value | Volume |
| $1.24 | $1.24 | $1.20 | $103.7K | 85.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 12091 | $1.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 9720 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |